Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06594848 · ClinicalTrials.gov registry record · NA
Effects of a Black Rice Extract and Anthocyanidin Metabolites on the Synthesis and Release of BDNF in Healthy Subjects
A NA study of Depression, Anxiety and Cognition - Other, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06594848: Active NA study of Depression, Anxiety and Cognition - Other, sponsored by University of California, Davis.
NCT06594848 is a NA study of Depression, Anxiety and Cognition - Other that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 12 participants, below the 425-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06594848, a NA study of Depression, Anxiety and Cognition - Other, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to investigate the effect of black rice extract (BRE) supplementation on levels of BDNF, which is a key molecule in cognition in healthy volunteers. The main questions to answer are: Does single BRE consumption increase levels of BDNF in the circulation in healthy men and women? Does single BRE consumption impact BDNF gene expression in cells isolated from the blood? Researchers will compare BRE to a placebo (a look-alike supplement that contains no BRE) to see if BRE increases levels of BDNF in blood.
Primary Outcome
BDNF will be measured in the serum using ELISA kit following the manufacturers' instruction
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Black rice extract
Study Locations (1)
California
- Ragle Human Nutrition Research Center, Academic Surge II - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT06594848 still lists
NCT06594848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 425-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Depression, Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06594848 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06594848 about?
NCT06594848 is a clinical study titled "Effects of a Black Rice Extract and Anthocyanidin Metabolites on the Synthesis and Release of BDNF in Healthy Subjects". The goal of this clinical trial is to investigate the effect of black rice extract (BRE) supplementation on levels of BDNF, which is a key molecule in cognition in healthy volunteers. The main questions to answer are: Does single BRE consumption increase levels of BDNF in the circulation in healthy...
What is the current status of trial NCT06594848?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-09-15. Estimated completion is 2026-11-30.
What conditions does trial NCT06594848 study?
This clinical trial studies the following conditions: Depression, Anxiety, Cognition - Other.
What interventions are being tested in trial NCT06594848?
The interventions under investigation include: Placebo (OTHER), Black rice extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06594848?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06594848 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06594848's enrollment target sits among peer trials
12 41st of 40 the lowest of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
SUpport From PEeRs to Expand Access Study - Community
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI